What you don't know can hurt you: Adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1650-1654

  Lerman, Caryn ^a   Hughes, Chanita ^a   Lemon, Stephen J ^a   Main, David ^a   Snyder, Carrie ^a   Durham, Carolyn ^a   Narod, Steven ^a   Lynch, Henry T ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; FAMILIAL CANCER; FEMALE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

EID: 0031833970     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1650     Document Type: Article

References (18)

1. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene. BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
2. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
3. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 273:577-585, 1995
4. Hartmann L, Jenkins R, Schaid D, et al: Prophylactic mastectomy (PM): Preliminary retrospective cohort analysis. Proc Am Assoc Cancer Res 38:168, 1997 (abstr)
5. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 275:1885-1892, 1996
6. Croyle RT, Smith KR, Botkin JR, et al: Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol 16:63-72, 1997
7. Serova O, Montagna M, Torchard, et al: A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 58:51-52, 1996
8. Narod SA, Ford D, Devilee P, et al: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56:254-264, 1995
9. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
10. Hendrix CC, Jurich AP, Schumm WR: Validation of the Impact of Event Scale on a sample of American Vietnam veterans. Psychol Rep 75:321-322, 1994
11. Creamer M, Burgess P, Pattison P: Reaction to trauma: A cognitive processing model. J Abnorm Psychol 101:452-459, 1992
12. Radloff LS: The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1:385-401, 1977
13. Zeger SL, Liang K-Y: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
14. Wiggins S, Whyte P, Muggins M, et al: The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 327:1401-1405, 1992
15. Tibben A, Duivenvoorden HJ, Vegter-van der Vlis M, et al: Presymptomatic DNA testing for Huntington disease: Identifying the need for psychological intervention. Am J Med Genet 48:137-144, 1993
16. Lerman C, Lustbader E, Rimer B, et al: Effects of individualized breast cancer risk counseling: A randomized trial. J Natl Cancer Inst 87:286-292, 1995
17. Kash KM, Holland JC, Halper MS, et al: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24-30, 1992
18. Lerman C, Biesecker B, Benkendorf J, et al: A controlled trial of pretest education approaches to enhance decision-making about BRCA1 gene testing. J Natl Cancer Inst 89:148-157, 1997